Comment: supratherapeutic response to ezetimibe administered with cyclosporine.
Ito
Matthew K
MK
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001384:Azetidines / Q000008:administration & dosage / Q000627:therapeutic use*; D008078:Cholesterol, LDL / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004347:Drug Interactions; D000069438:Ezetimibe; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D001384:Azetidines; D008078:Cholesterol, LDL; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000069438:Ezetimibe